Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-11-20

Clinical Trial Update: Assessing Continuous Non- Invasive Blood Glucose Sensor- Physical Logic AG [NA]

View source ↗

Summary

A clinical trial evaluating a continuous non-invasive blood glucose sensor by Physical Logic AG (sponsored by Rabin Medical Center) was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rabin Medical Center | Conditions: Type 1 Diabetes | NA | Status: TERMINATED